Table 3.
Baseline predictors of a ≥10 letter gain in best-corrected visual acuity.
| Variable | OR | 95% CI | P-value | |
|---|---|---|---|---|
| Upper | Lower | |||
| Sex | ||||
| Female | 0.243 | 0.041 | 1.430 | 0.118 |
| Male (ref.) | 1 | . | . | |
| Age | 1.033 | 0.945 | 1.128 | 0.477 |
| Diffuse retinal thickening | ||||
| 3-6mm | 6.030 | 0.941 | 38.656 | 0.058 |
| 1-3mm | 0.450 | 0.041 | 4.933 | 0.513 |
| ≤1mm | 0.996 | 0.014 | 69.310 | 0.998 |
| 0mm (ref.) | 1 | |||
| ONL cyst size | ||||
| Giant | 0.003 | 0.001 | 10.015 | 0.996 |
| Large | 2.126 | 0.541 | 8.633 | 0.275 |
| Small | 0.839 | 0.156 | 4.508 | 0.938 |
| No (ref.) | 1 | |||
| IS-OS continuity | ||||
| Completely disrupted | 0.005 | 0.011 | 12.021 | 0.996 |
| Partially continuous | 1.052 | 0.343 | 3.224 | 0.929 |
| Completely continuous (ref.) | 1 | |||
| HRF foci-quantity | ||||
| Many (≥11) | 0.166 | 0.021 | 1.324 | 0.090 |
| Few (2-10) | 0.250 | 0.035 | 1.765 | 0.164 |
| Absent (ref.) | 1 | |||
| ERM | ||||
| Yes | 0.346 | 0.061 | 1.976 | 0.233 |
| No (ref.) | 1 | |||
| DR type | ||||
| PDR | 0.602 | 0.112 | 3.237 | 0.555 |
| Severe NPDR | 0.799 | 0.165 | 3.879 | 0.781 |
| Moderate NPDR (ref.) | 1 | |||
| SRD | ||||
| Yes | 1.366 | 0.293 | 6.098 | 0.708 |
| No (ref.) | 1 | |||
CI, confidence interval; ERM, epiretinal membrane; ref, reference; HRF, hyperreflective foci; IS-OS, inner segment-outer segment; NPDR, non- proliferative diabetic retinopathy; ONL, outer nuclear layer; OR,Odds ratio; PDR, proliferative diabetic retinopathy; PVD, posterior vitreous detachment; SRD, serous retinal detachment; VMA, vitreomacular adhesion; VMT, vitreomacular traction.